Welcome to isctr.org
Update: Consensus Strategies for Device Development for Cardiovascular Disease
Building on our highly successful summit at the 2016 TCT meeting, ISCTR is collaborating with innovators, regulators, industry leaders, and others to create strategies and methodologies designed to achieve the rapid and cost-effective translation of cardiovascular device advances into clinical practice.
To that end, we are taking our next step in the process and convening a critical meeting in May of various working groups to break down the methodologies involved in the development of aortic/pulmonic valves, mitral/tricuspid valves, stents, and catheter ablation devices. We will begin this important meeting with a look at everything from data aggregation to guideline integration to the FDA approval process.
Check back often to get more details about this meeting as they are available. You can learn more about the genesis of this meeting through our coverage of our 2016 TCT summit here.
ISCTR Summit On Cardiovascular Devices
The Translational Pathways for Cardiovascular Devices:
Current and Future Directions
TCT 2016 Satellite Session
View presentations from the 9th Annual ISCTR Symposium
Become an ISCTR Member
ISCTR’s member newsletter
International Society for
Cardiovascular Translational Research
The International Society for Cardiovascular Translational Research (ISCTR) is a non-profit organization that was founded in 2007 by Dr Nabil Dib with a goal to expedite scientific discovery to clinical application (patients).
The Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Medicine
Journal of Cardiovascular Translational Research
Click for details on Springer…